Efficacy of mometasone furoate nasal spray for nasal symptoms, quality of life, rhinitis-disturbed sleep, and nasal nitric oxide in patients with perennial allergic rhinitis

Allergy and Asthma Proceedings

Volumn 33, Issue 2, 2012, Pages

  Yamada, Takechiyo ^a   Yamamoto, Hideyuki ^a   Kubo, Seita ^a   Sakashita, Masafumi ^a   Tokunaga, Takahiro ^a   Susuki, Dai ^a   Narita, Norihiko ^a   Ogi, Kazuhiro ^a   Kanno, Masafumi ^a   Yamashita, Shinji ^a   Terasawa, Yuko ^a   Sugano, Yuichiro ^a   Masada, Mikio ^a   Fujieda, Shigeharu ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MOMETASONE FUROATE; NITRIC OXIDE; PLACEBO;

ADOLESCENT; ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERENNIAL RHINITIS; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SLEEP DISORDER; SLEEP PARAMETERS; SLEEP QUALITY;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; ANTI-ALLERGIC AGENTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; NASAL SPRAYS; NITRIC OXIDE; PREGNADIENEDIOLS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RHINITIS, ALLERGIC, PERENNIAL; SLEEP; SLEEP DISORDERS;

EID: 84860261615     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2012.33.3509     Document Type: Article

References (26)

1. Sakashita M, Hirota T, Harada M, et al. Prevalence of allergic rhinitis and sensitization to common aeroallergens in a Japanese population. Int Arch Allergy Immunol 151:255-261, 2010.
2. Plaut M, and Valentine MD. Clinical practice. Allergic rhinitis. N Engl J Med 353:1934-1944, 2005.
3. Hochhaus G. Pharmacokinetic/pharmacodynamic profile of mometasone furoate nasal spray: Potential effects on clinical safety and efficacy. Clin Ther 30:1-13, 2008. (Pubitemid 351834720)
4. Weiner JM, Abramson MJ, and Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: Systematic review of randomised controlled trials. BMJ 317: 1624-1629, 1998. (Pubitemid 28554544)
5. Dupclay L Jr, and Doyle J. Assessment of intranasal corticosteroid use in allergic rhinitis: Benefits, costs, and patient preferences. Am J Manag Care 13(suppl):S335-S340, 2002.
6. Herman H. Once-daily administration of intranasal corticosteroids for allergic rhinitis: A comparative review of efficacy, safety, patient preference, and cost. Am J Rhinol 21:70-79, 2007. (Pubitemid 46231494)
7. Penagos M, Compalati E, Tarantini F, et al. Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials. Allergy 63:1280-1291, 2008.
8. Okubo K, Uchida E, and Nogami S. Levocabastine nasal spray significantly improves perennial allergic rhinitis: A single-blind placebo-controlled study. Auris Nasus Larynx 37:436-442, 2010.
9. Okubo K, Kurono Y, Fujieda S, et al. Japanese guideline for allergic rhinitis. Allergol Int 60:171-189, 2011.
10. Yamamoto H, Yamada T, Kubo S, et al. Efficacy of oral olopatadine hydrochloride for the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled study. Allergy Asthma Proc 31:296-303, 2010.
11. Makino Y, Noguchi E, Takahashi N, et al. Apolipoprotein A-IV is a candidate target molecule for the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 126:1163-1169, 2010.
12. Takegami M, Suzukamo Y, Wakita T, et al. Development of a Japanese version of the Epworth Sleepiness Scale (JESS) based on Item Response Theory. Sleep Med 10:556-565, 2009.
13. American Thoracic Society; European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med 171:912-930, 2005.
14. Salapatek AM, Patel P, Gopalan G, et al. Mometasone furoate nasal spray provides early, continuing relief of nasal congestion and improves nasal patency in allergic patients. Am J Rhinol Allergy 24:433-438, 2010.
15. Prenner BM, Lanier BQ, Bernstein DI, et al. Mometasone furoate nasal spray reduces the ocular symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol 125:1247-1253, 2010.
16. Baiardini I, Bousquet PJ, Brzoza Z, et al. Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: A GA(2)LEN taskforce position paper. Allergy 65:290-295, 2010.
17. Hiraki N, Suzuki H, Udaka T, et al. Snoring, daytime sleepiness, and nasal obstruction with or without allergic rhinitis. Arch Otolaryngol Head Neck Surg 134:1254-1257, 2008.
18. Meltzer EO, Munafo DA, Chung W, et al. Intranasal mometasone furoate therapy for allergic rhinitis symptoms and rhinitisdisturbed sleep. Ann Allergy Asthma Immunol 105:65-74, 2010.
19. Palm JP, Graf P, Lundberg JO, et al. Characterization of exhaled nitric oxide: Introducing a new reproducible method for nasal nitric oxide measurements. Eur Respir J 16:236-241, 2000. (Pubitemid 30624941)
20. Stark H, Purokivi M, Kiviranta J, et al. Short-term and seasonal variations of exhaled and nasal NO in healthy subjects. Respir Med 101:265-271, 2007. (Pubitemid 46075975)
21. Arnal JF, Didier A, Rami J, et al. Nasal nitric oxide is increased in allergic rhinitis. Clin Exp Allergy 27:358-362, 1997. (Pubitemid 27183357)
22. Kharitonov SA, Rajakulasingam K, O'Connor B, et al. Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids. J Allergy Clin Immunol 99:58-64, 1997.
23. Baraldi E, Azzolin NM, Carrà S, et al. Effect of topical steroids on nasal nitric oxide production in children with perennial allergic rhinitis: A pilot study. Respir Med 92:558-561, 1998. (Pubitemid 28162171)
24. Howarth PH, Persson CG, Meltzer EO, et al. Objective monitoring of nasal airway inflammation in rhinitis. J Allergy Clin Immunol 115:S414-S441, 2005. (Pubitemid 40320994)
25. Wilson AM, Dempsey OJ, Sims EJ, et al. A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma. Clin Exp Allergy 31:616-624, 2001. (Pubitemid 34204287)
26. Sivam A, Jeswani S, Reder L, et al. Olfactory cleft inflammation is present in seasonal allergic rhinitis and is reduced with intranasal steroids. Am J Rhinol Allergy 24:286-290, 2010.